Annual ROE
4370.31%
+5361.26%+541.02%
December 31, 2023
Summary
- As of February 8, 2025, AKTX annual return on equity is 4370.31%, with the most recent change of +5361.26% (+541.02%) on December 31, 2023.
- During the last 3 years, AKTX annual ROE has risen by +4552.33% (+2501.01%).
- AKTX annual ROE is now at all-time high.
Performance
AKTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
568.64%
-238.29%-29.53%
September 1, 2024
Summary
- As of February 8, 2025, AKTX quarterly return on equity is 568.64%, with the most recent change of -238.29% (-29.53%) on September 1, 2024.
- Over the past year, AKTX quarterly ROE has dropped by -238.29% (-29.53%).
- AKTX quarterly ROE is now -88.56% below its all-time high of 4970.01%, reached on March 31, 2024.
Performance
AKTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AKTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +541.0% | -29.5% |
| 3 y3 years | +2501.0% | +302.5% |
| 5 y5 years | +763.3% | +152.6% |
AKTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +541.0% | -88.6% | +172.5% |
| 5 y | 5-year | at high | +102.0% | -88.6% | +126.2% |
| alltime | all time | at high | +102.0% | -88.6% | +126.2% |
Akari Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 568.64%(-29.5%) |
| Jun 2024 | - | 806.93%(-83.8%) |
| Mar 2024 | - | 4970.01%(-733.8%) |
| Dec 2023 | 4370.31%(-541.0%) | -784.17%(+271.6%) |
| Sep 2023 | - | -211.04%(+95.7%) |
| Jun 2023 | - | -107.82%(+91.9%) |
| Mar 2023 | - | -56.20%(-69.6%) |
| Dec 2022 | -990.95%(+215.9%) | - |
| Jun 2022 | - | -184.77%(-10.6%) |
| Mar 2022 | - | -206.71%(-33.4%) |
| Dec 2021 | -313.69%(+72.3%) | -310.56%(+10.6%) |
| Sep 2021 | - | -280.85%(-13.7%) |
| Jun 2021 | - | -325.41%(-8.7%) |
| Mar 2021 | - | -356.43%(+1.2%) |
| Dec 2020 | -182.02%(-99.9%) | -352.25%(-50.7%) |
| Sep 2020 | - | -714.15%(-29.7%) |
| Jun 2020 | - | -1016.05%(-47.9%) |
| Mar 2020 | - | -1950.28%(-10.1%) |
| Dec 2019 | -221.66 K% | -2169.59%(+100.8%) |
| Sep 2019 | - | -1080.47%(+40.5%) |
| Jun 2019 | - | -768.77%(+70.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -450.78%(+88.9%) |
| Dec 2018 | -658.87%(+219.3%) | -238.61%(+15.2%) |
| Sep 2018 | - | -207.18%(-10.3%) |
| Jun 2018 | - | -231.06%(+65.9%) |
| Mar 2018 | - | -139.27%(-25.8%) |
| Dec 2017 | -206.36%(+287.9%) | -187.68%(+37.3%) |
| Sep 2017 | - | -136.67%(+90.3%) |
| Jun 2017 | - | -71.80%(-10.6%) |
| Mar 2017 | - | -80.33%(+79.4%) |
| Dec 2016 | -53.20%(-42.8%) | -44.77%(+484.5%) |
| Sep 2016 | - | -7.66%(-93.4%) |
| Jun 2016 | - | -116.84%(-13.9%) |
| Mar 2016 | - | -135.65%(-29.9%) |
| Dec 2015 | -93.02%(+6.2%) | -193.55%(-56.9%) |
| Sep 2015 | - | -448.93%(+98.1%) |
| Jun 2015 | - | -226.61%(+3.7%) |
| Mar 2015 | - | -218.45%(-8.5%) |
| Dec 2014 | -87.60%(+40.7%) | -238.65% |
| Dec 2013 | -62.26%(-149.0%) | - |
| Dec 2012 | 127.02%(+49.0%) | - |
| Dec 2011 | 85.27% | - |
FAQ
- What is Akari Therapeutics annual return on equity?
- What is the all time high annual ROE for Akari Therapeutics?
- What is Akari Therapeutics annual ROE year-on-year change?
- What is Akari Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Akari Therapeutics?
- What is Akari Therapeutics quarterly ROE year-on-year change?
What is Akari Therapeutics annual return on equity?
The current annual ROE of AKTX is 4370.31%
What is the all time high annual ROE for Akari Therapeutics?
Akari Therapeutics all-time high annual return on equity is 4370.31%
What is Akari Therapeutics annual ROE year-on-year change?
Over the past year, AKTX annual return on equity has changed by +5361.26% (+541.02%)
What is Akari Therapeutics quarterly return on equity?
The current quarterly ROE of AKTX is 568.64%
What is the all time high quarterly ROE for Akari Therapeutics?
Akari Therapeutics all-time high quarterly return on equity is 4970.01%
What is Akari Therapeutics quarterly ROE year-on-year change?
Over the past year, AKTX quarterly return on equity has changed by -238.29% (-29.53%)